Draig Therapeutics
Draig Therapeutics48Draig Therapeutics
Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.
About
What does Draig Therapeutics do?
Draig Therapeutics is developing transformative neuropsychiatric therapies designed to restore the brain to a healthier state. Their approach utilizes highly specific neuromodulators, with a lead program, DT-101, targeting major depressive disorder by potentiating AMPA receptors. The company is committed to co-creating with patients and care partners to develop best-in-class treatments for prevalent and underserved neuropsychiatric disorders.
What is Draig Therapeutics's revenue?
StartupHub estimates Draig Therapeutics's annual revenue at $4.2M (range $1.4M to $13.7M, 31% confidence), based on comparable companies in the sector.
What is Draig Therapeutics's valuation?
StartupHub estimates Draig Therapeutics's effective valuation at $257.4M (range $162.5M to $390.0M, 23% confidence), based on comparable companies in the sector.
How much funding has Draig Therapeutics raised?
Draig Therapeutics has raised a total of $65M in funding. The most recent round on record is Series B.
Where is Draig Therapeutics headquartered?
Draig Therapeutics is headquartered in Newton, Massachusetts, United States.
What industry does Draig Therapeutics operate in?
Draig Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare, Neuroscience, Biotech, Drug Discovery.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Scan this site yourselfStrength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.
Check any domain freeGoogle PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
Open in PageSpeed InsightsStar ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.
“Ion channel ligands in clinical development – Quarterly review (Q4 2025). The main focus of this series is to highlight the progress being made in ion channel clinical drug development, which is a key validation parameter for target selecti…”
View on Reddit“Cardiff (Wales) Based Biotech Draig Therapeutics Emerge From Stealth.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.